The latest news from Europe
Provided by AGPThe Business Research Company's Aminoglycosides Market Forecast to 2030: Analysis of Growth, Opportunities, Share, and Competitive Landscape
LONDON, GREATER LONDON, UNITED KINGDOM, May 7, 2026 /EINPresswire.com/ -- "The aminoglycosides market has been witnessing notable momentum recently, driven by various healthcare needs and expanding applications. This segment of antibiotics plays a critical role in treating infections and is poised for steady growth in the coming years. Let’s explore the current market outlook, key drivers, regional dominance, and anticipated trends shaping the aminoglycosides sector.
Market Size and Growth Outlook for the Aminoglycosides Market
The aminoglycosides market has experienced significant expansion over recent years. Valued at $1.91 billion in 2025, it is projected to reach $2.02 billion by 2026, registering a compound annual growth rate (CAGR) of 5.8%. This historic growth has been fueled by factors such as the high prevalence of abdominal and urinary tract infections, extensive use of broad-spectrum antibiotics, reliance on traditional manufacturing methods, limited regulatory restrictions in veterinary applications, and a strong demand for ophthalmic solutions. Looking ahead, the market is anticipated to grow robustly, reaching $2.56 billion by 2030 with a CAGR of 6.0%. Drivers for this forecasted growth include intensified research and development in targeted aminoglycoside treatments, a rising awareness of antibiotic resistance, the adoption of advanced drug delivery technologies, expansion in the veterinary healthcare sector, and increased applications in personalized medicine. Key emerging trends include a growing incidence of gram-negative bacterial infections, rising veterinary usage, innovation in novel aminoglycoside derivatives, a shift towards injectable and targeted formulations, and expanded ophthalmic and inhalation uses.
Download a free sample of the aminoglycosides market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8515&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=May_PR
Understanding Aminoglycosides and Their Medical Applications
Aminoglycosides are a class of antibiotics that work by inhibiting protein synthesis within bacteria. They are primarily used to combat infections caused by aerobic gram-negative bacilli, particularly in cases involving the abdomen and urinary tract. Additionally, these antibiotics are effective in treating bacteremia and endocarditis, making them vital in managing serious infections.
Significant Role of Animal Disease Outbreaks in Market Growth
One of the prominent factors driving the aminoglycosides market is the rising frequency of animal disease outbreaks. Animal diseases disrupt the normal functioning and health of animals, requiring effective treatment options. Aminoglycosides such as amikacin and gentamicin are commonly employed in veterinary medicine to combat these conditions. For example, in July 2025, GOV.UK reported a notable increase in leptospirosis cases in England, from 70 in 2023 to 102 in 2024 — a 45.7% rise. Similarly, pasteurellosis cases rose to 890 in 2024 from 815 the previous year. These growing incidences of animal diseases are expected to continue supporting market growth for aminoglycosides.
View the full aminoglycosides market report:
https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=May_PR
Pet Ownership Trends Boosting Aminoglycosides Market Demand
The surge in pet ownership is another key driver propelling the aminoglycosides market forward. Pet ownership, which involves caring for companion animals at home, expands the customer base for veterinary pharmaceuticals and drives preventive healthcare measures for pets. This trend encourages increased investment in medications catering to a variety of animal health needs. For instance, data from Improve International in March 2023 highlights that the UK has around 38 million pets across 16.2 million households — roughly 57% of all households. This rise in pet ownership directly contributes to the growing demand for aminoglycosides in veterinary care.
Regional Distribution and Market Leadership of Aminoglycosides
In 2025, the Asia-Pacific region held the largest share of the aminoglycosides market. However, North America is anticipated to be the fastest-growing region during the forecast period. The overall market analysis includes key geographic areas such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad perspective on global developments in this sector.
Browse Through More Reports Similar to the Global Aminoglycosides Market 2026, By The Business Research Company
Aminoglycosides Market Report 2026
https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report
Amino Acid Market Report 2026
https://www.thebusinessresearchcompany.com/report/amino-acid-global-market-report
Bionematicides Market Report 2026
https://www.thebusinessresearchcompany.com/report/bionematicides-global-market-report
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.